USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Dec 6, 2021 | Sep 2021 | $-0.34 | $-0.46 | $-0.22 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Dec 6, 2021 | Sep 2021 | $0.00 | $0.00 | $500.00 |
Edesa Biotech, Inc's next earnings date is Monday, Dec 6, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 0 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Sep 2022 | 2 | $-1.33 | $-2.00 | $-0.66 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $0.00 | $0.00 | $0.00 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Sep 2022 | 0 / 0 | $-1.33 | $-1.33 | $-1.32 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 0 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Sep 2022 | 2 | $24.48M | $0.00 | $48.96M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Dec 6, 2021 | Sep 2021 | $-0.34 | - | - |
| Aug 13, 2021 | Jun 2021 | $-0.14 | $-0.46 | -227.00% |
| May 14, 2021 | Mar 2021 | $-0.39 | $-0.81 | -107.69% |
| Feb 16, 2021 | Dec 2020 | $-0.22 | $-0.26 | -18.18% |
| Dec 7, 2020 | Sep 2020 | $-0.23 | $-0.22 | 4.35% |
| Aug 12, 2020 | Jun 2020 | $-0.23 | $-0.20 | 13.04% |
| May 15, 2020 | Mar 2020 | $-0.26 | $-0.17 | 34.62% |
| Feb 13, 2020 | Dec 2019 | - | $-0.15 | - |
| May 8, 2019 | Mar 2019 | - | $-1.86 | - |
| Feb 5, 2019 | Dec 2018 | - | $-1.58 | - |
| Nov 30, 2018 | Sep 2018 | - | $-1.27 | - |
| Aug 8, 2018 | Jun 2018 | - | $-2.25 | - |
| May 8, 2018 | Mar 2018 | - | $-5.40 | - |
| Feb 5, 2018 | Dec 2017 | - | $-5.59 | - |
| Dec 1, 2017 | Sep 2017 | - | $-4.87 | - |
| Aug 9, 2017 | Jun 2017 | $-0.77 | $-0.84 | -9.09% |
| May 9, 2017 | Mar 2017 | $-0.70 | $-0.77 | -10.00% |
| Feb 6, 2017 | Dec 2016 | $-0.70 | $-1.05 | -50.00% |
| Dec 14, 2016 | Sep 2016 | $-0.91 | $-0.91 | - |
| Aug 9, 2016 | Jun 2016 | $-0.84 | $-0.98 | -16.67% |
| May 9, 2016 | Mar 2016 | $-0.70 | $-0.70 | - |
| Feb 8, 2016 | Dec 2015 | - | $-8.18 | - |
| Dec 14, 2015 | Sep 2015 | $0.05 | $-0.19 | -480.00% |
| Aug 10, 2015 | Jun 2015 | - | $2.29 | - |
| May 11, 2015 | Mar 2015 | - | $-2.25 | - |
| Feb 9, 2015 | Dec 2014 | - | $-7.10 | - |
| Nov 13, 2014 | Sep 2014 | $-1.40 | $-2.80 | -100.00% |
| Jul 10, 2014 | Jun 2014 | - | $9.75 | - |
| Apr 30, 2014 | Mar 2014 | - | $-1.33 | - |
| Jan 29, 2014 | Dec 2013 | - | $-31.96 | - |
| Aug 31, 2013 | Jun 2013 | - | $-71.40 | - |
| May 31, 2013 | Mar 2013 | - | $-9.20 | - |
| Feb 28, 2013 | Dec 2012 | - | $-30.20 | - |
| Nov 30, 2012 | Sep 2012 | - | $-6.84 | - |
| Aug 31, 2012 | Jun 2012 | - | $-23.56 | - |
| May 31, 2012 | Mar 2012 | - | $-10.76 | - |
| Feb 29, 2012 | Dec 2011 | - | $-8.08 | - |
| Nov 30, 2011 | Sep 2011 | - | $-6.61 | - |
| Aug 31, 2011 | Jun 2011 | - | $-12.37 | - |
| May 31, 2011 | Mar 2011 | - | $-13.13 | - |
| Feb 28, 2011 | Dec 2010 | - | $-41.19 | - |
| Nov 30, 2010 | Sep 2010 | - | $-11.79 | - |
| Aug 31, 2010 | Jun 2010 | - | $-4.30 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Dec 6, 2021 | Sep 2021 | $-0.91 | $-1.53 | - |
| Dec 7, 2020 | Sep 2020 | $-0.66 | $-4.18 | - |
| Nov 30, 2018 | Sep 2018 | $0.00 | $-14.51 | - |
| Dec 1, 2017 | Sep 2017 | $0.00 | $-7.53 | - |
| Dec 14, 2016 | Sep 2016 | - | $-10.77 | - |
| Dec 14, 2015 | Sep 2015 | - | $-7.25 | - |
| Nov 13, 2014 | Sep 2014 | - | $-137.14 | - |
| Nov 30, 2012 | Sep 2012 | - | $-49.24 | - |
| Nov 30, 2011 | Sep 2011 | - | $-73.30 | - |
| Nov 30, 2010 | Sep 2010 | - | $-16.09 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Dec 6, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 13, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 14, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Feb 16, 2021 | Dec 2020 | $100.00K | $500.00 | 0.01% |
| Dec 7, 2020 | Sep 2020 | $50.00K | $500.00 | 0.01% |
| Aug 12, 2020 | Jun 2020 | $50.00K | $109.99K | 2.20% |
| May 15, 2020 | Mar 2020 | $50.00K | $110.52K | 2.21% |
| Feb 13, 2020 | Dec 2019 | - | $107.80K | - |
| May 8, 2019 | Mar 2019 | - | $117.76K | - |
| Feb 5, 2019 | Dec 2018 | - | $53.03K | - |
| Nov 30, 2018 | Sep 2018 | - | $54.26K | - |
| Aug 8, 2018 | Jun 2018 | - | $70.00K | - |
| May 8, 2018 | Mar 2018 | - | $60.00K | - |
| Feb 5, 2018 | Dec 2017 | $610.00K | $20.49K | 0.03% |
| Dec 1, 2017 | Sep 2017 | $0.00 | $50.00K | - |
| Aug 9, 2017 | Jun 2017 | - | $20.00K | - |
| May 9, 2017 | Mar 2017 | - | $60.00K | - |
| Feb 6, 2017 | Dec 2016 | - | $141.86K | - |
| Dec 14, 2016 | Sep 2016 | - | $280.00K | - |
| Aug 9, 2016 | Jun 2016 | - | $180.00K | - |
| May 9, 2016 | Mar 2016 | - | $330.00K | - |
| Feb 8, 2016 | Dec 2015 | - | $490.00K | - |
| Dec 14, 2015 | Sep 2015 | - | $200.00K | - |
| Aug 10, 2015 | Jun 2015 | - | $157.75K | - |
| May 11, 2015 | Mar 2015 | - | $187.63K | - |
| Feb 9, 2015 | Dec 2014 | - | $212.66K | - |
| Nov 13, 2014 | Sep 2014 | - | - | - |
| Jul 10, 2014 | Jun 2014 | - | $119.28K | - |
| Apr 30, 2014 | Mar 2014 | - | $102.58K | - |
| Jan 29, 2014 | Dec 2013 | - | $91.10K | - |
| Aug 31, 2013 | Jun 2013 | - | $295.05K | - |
| May 31, 2013 | Mar 2013 | - | $73.21K | - |
| Feb 28, 2013 | Dec 2012 | - | $61.48K | - |
| Nov 30, 2012 | Sep 2012 | - | $115.73K | - |
| Aug 31, 2012 | Jun 2012 | - | $49.28K | - |
| May 31, 2012 | Mar 2012 | - | $43.17K | - |
| Feb 29, 2012 | Dec 2011 | - | $58.24K | - |
| Nov 30, 2011 | Sep 2011 | - | $135.37K | - |
| Aug 31, 2011 | Jun 2011 | - | $40.29K | - |
| May 31, 2011 | Mar 2011 | - | $41.59K | - |
| Feb 28, 2011 | Dec 2010 | - | $545.42K | - |
| Nov 30, 2010 | Sep 2010 | - | $69.90K | - |
| Aug 31, 2010 | Jun 2010 | - | $544.70K | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Dec 6, 2021 | Sep 2021 | $0.00 | - | - |
| Dec 7, 2020 | Sep 2020 | $250.00K | $328.80K | 31.52% |
| Nov 30, 2018 | Sep 2018 | $2.66M | $211.85K | - |
| Dec 1, 2017 | Sep 2017 | $0.00 | $228.29K | - |
| Dec 14, 2016 | Sep 2016 | - | $1.27M | - |
| Dec 14, 2015 | Sep 2015 | - | $758.69K | - |
| Nov 13, 2014 | Sep 2014 | - | $372.13K | - |
| Nov 30, 2012 | Sep 2012 | - | $286.05K | - |
| Nov 30, 2011 | Sep 2011 | - | $697.19K | - |
| Nov 30, 2010 | Sep 2010 | - | $854.84K | - |
EDSA's next earnings date is Monday, Dec 6, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 2 analysts, the average EPS estimation for Edesa Biotech, Inc's next quarterly earnings is $-0.34, with a low EPS estimation of $-0.42, and a high estimation of $-0.27.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.34, the last 2 month trend is $-0.34, and the 3 month trend is $-0.31.
Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Edesa Biotech, Inc's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.
EDSA's earnings per share (EPS) was $-0.46, missing the consensus analysts forecast of $-0.14 by -227.00%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -43.48%, and lower than the same period a year before (Jun 2020) by 128.90%.
Revenues were $0.00.
The company reported a net income of $-4.76M.Free cash flow for the quarter was $-3.12M , compared to $-7.18M last quarter and $-1.38M a year before.
EDSA ended the quarter with $121.23K in total debt, a decrease of -12.24% compared to the previous quarter, and a decrease of -31.46% compared to the same quarter a year before.
Edesa Biotech, Inc's previous annual earnings date was Dec 7, 2020 for its fiscal year ended Sep 30, 2020.
EDSA's earnings per share (EPS) was $-4.18.
Revenues were $328.80K, better than the forecast of $250.00K by 31.52%, and down by -19.97% from previous year's revenue.
The company reported a net income of $-6.36M.
Edesa Biotech, Inc reported a free cash flow of $-5.02M for its fiscal year, compared to $-4.85M a year ago.
The company ended the fiscal year with $164.19K in total debt. lala
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
